Soluble urokinase plasminogen activator receptor (suPAR) as a prognostic marker of mortality in healthy, general and patient populations: protocol for a systematic review and meta-analysis.
Jens Emil Vang PetersenThomas KallemoseKaren D BartonAvshalom CaspiLine Jee Hartmann RasmussenPublished in: BMJ open (2020)
CRD42020167401.